Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
All content for Footprints & Impacts Podcast is the property of EHAC-ASEC and ASEQ-EHAQ and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
MCS and Human Rights: Missed Opportunities and the Road Ahead with Paul-Claude Bérubé, LLB
Footprints & Impacts Podcast
49 minutes
1 month ago
MCS and Human Rights: Missed Opportunities and the Road Ahead with Paul-Claude Bérubé, LLB
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
Footprints & Impacts Podcast
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
